Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out the time it takes to absorb, distribute, breakdown
and remove the drug from the body, safety and tolerability of AMG 581 in healthy participants
and subjects with schizophrenia.